Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)

Background: To determine the prognostic significance of NRP-1 (CD304) expression in paediatric B-lineage Acute Lymphoblastic Leukaemia (ALL) patients. Methods: In this comparative study newly diagnosed cases (aged 1-15 years) of B-ALL were selected. Age and sex matched, 21 healthy controls we...

Full description

Bibliographic Details
Main Authors: Moizza Sahar, Fauzia Shafi Khan
Format: Article
Language:English
Published: Rawalpindi Medical University 2019-05-01
Series:Journal of Rawalpindi Medical College
Subjects:
Online Access:https://www.journalrmc.com/index.php/JRMC/article/view/1075
_version_ 1818964627441057792
author Moizza Sahar
Fauzia Shafi Khan
author_facet Moizza Sahar
Fauzia Shafi Khan
author_sort Moizza Sahar
collection DOAJ
description Background: To determine the prognostic significance of NRP-1 (CD304) expression in paediatric B-lineage Acute Lymphoblastic Leukaemia (ALL) patients. Methods: In this comparative study newly diagnosed cases (aged 1-15 years) of B-ALL were selected. Age and sex matched, 21 healthy controls were also included in the study to assess the NRP-1 expression on peripheral blood lymphocytes. A minimum 1ml of blood and bone marrow aspirate samples were taken in EDTA vacutainer and immunophenotyping was done on gated blast cells using an extensive panel of antibodies including myeloid markers (CD13, CD33 and cytoplasmic anti- MPO) and lymphoid markers (CD34, CD2, CD3, CD5, CD7, CD4, CD8, HLA DR, CD10, CD19, CD22; cytoplasmic CD3, CD22, CD79a and nuclear anti- TdT). The sample was considered NRP-1 positive if 20% or more of the gated blast cells expressed it . Man-Witney U test and Kruskal Wallis test were used for non-parametric data. The p value <0.05 was considered significant. Results: Out of 66 B-ALL patients, 53% were males. There were 20 (30%) NRP-1 positive and 46 (70%) NRP-1 negative patients. The prognosis of NRP-1 positive group was poor as compared to NRP-1 negative group with high blast percentage (80%) (p= 0.042), low morphological remission rate (21%) (p=0.004) and low survival rate (29%) (p=0.009). The mean survival days in dead patients was also less (22.75 days). Conclusion: NRP-1 over expression is associated with disease progression and severity in paediatric B-ALL patients.
first_indexed 2024-12-20T13:04:07Z
format Article
id doaj.art-d8db1de5648d4580ab68597231918f1e
institution Directory Open Access Journal
issn 1683-3562
1683-3570
language English
last_indexed 2024-12-20T13:04:07Z
publishDate 2019-05-01
publisher Rawalpindi Medical University
record_format Article
series Journal of Rawalpindi Medical College
spelling doaj.art-d8db1de5648d4580ab68597231918f1e2022-12-21T19:39:50ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702019-05-01231Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)Moizza Sahar0Fauzia Shafi Khan1Department of Haematology, University of Health SciencesChildren Hospital and Institute of Child Health,Ferozpur Road, LahoreBackground: To determine the prognostic significance of NRP-1 (CD304) expression in paediatric B-lineage Acute Lymphoblastic Leukaemia (ALL) patients. Methods: In this comparative study newly diagnosed cases (aged 1-15 years) of B-ALL were selected. Age and sex matched, 21 healthy controls were also included in the study to assess the NRP-1 expression on peripheral blood lymphocytes. A minimum 1ml of blood and bone marrow aspirate samples were taken in EDTA vacutainer and immunophenotyping was done on gated blast cells using an extensive panel of antibodies including myeloid markers (CD13, CD33 and cytoplasmic anti- MPO) and lymphoid markers (CD34, CD2, CD3, CD5, CD7, CD4, CD8, HLA DR, CD10, CD19, CD22; cytoplasmic CD3, CD22, CD79a and nuclear anti- TdT). The sample was considered NRP-1 positive if 20% or more of the gated blast cells expressed it . Man-Witney U test and Kruskal Wallis test were used for non-parametric data. The p value <0.05 was considered significant. Results: Out of 66 B-ALL patients, 53% were males. There were 20 (30%) NRP-1 positive and 46 (70%) NRP-1 negative patients. The prognosis of NRP-1 positive group was poor as compared to NRP-1 negative group with high blast percentage (80%) (p= 0.042), low morphological remission rate (21%) (p=0.004) and low survival rate (29%) (p=0.009). The mean survival days in dead patients was also less (22.75 days). Conclusion: NRP-1 over expression is associated with disease progression and severity in paediatric B-ALL patients.https://www.journalrmc.com/index.php/JRMC/article/view/1075NRP-1/CD304Pediatric B-lineage ALL PatientsMinimal Residual Disease(MRD),Flow Cytometry
spellingShingle Moizza Sahar
Fauzia Shafi Khan
Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
Journal of Rawalpindi Medical College
NRP-1/CD304
Pediatric B-lineage ALL Patients
Minimal Residual Disease(MRD),
Flow Cytometry
title Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
title_full Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
title_fullStr Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
title_full_unstemmed Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
title_short Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
title_sort significance of neuropilin 1 cd 304 expression in paediatric b lineage acute lymphoblastic leukemia all
topic NRP-1/CD304
Pediatric B-lineage ALL Patients
Minimal Residual Disease(MRD),
Flow Cytometry
url https://www.journalrmc.com/index.php/JRMC/article/view/1075
work_keys_str_mv AT moizzasahar significanceofneuropilin1cd304expressioninpaediatricblineageacutelymphoblasticleukemiaall
AT fauziashafikhan significanceofneuropilin1cd304expressioninpaediatricblineageacutelymphoblasticleukemiaall